These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25971283)

  • 1. Intra-abdominal pressure, Cardiac Index and vascular resistance during hyperthermic intraperitoneal chemotherapy: a prospective observational study.
    Schluermann CN; Hoeppner J; Benk C; Schmidt R; Loop T; Kalbhenn J
    Minerva Anestesiol; 2016 Feb; 82(2):160-9. PubMed ID: 25971283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy.
    Thanigaimani K; Mohamed F; Cecil T; Moran BJ; Bell J
    Colorectal Dis; 2013 Dec; 15(12):1537-42. PubMed ID: 24119169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global End-Diastolic Volume (GEDV) Could Be More Appropiate to Fluid Management Than Central Venous Pressure (CVP) During Closed Hyperthermic Intrabdominal Chemotherapy with CO
    Redondo FJ; Padilla D; Villarejo P; Baladron V; Faba P; Sánchez S; Muñoz-Rodríguez JR; Bejarano N
    J Invest Surg; 2018 Aug; 31(4):321-327. PubMed ID: 28557569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic Monitoring During Heated Intraoperative Intraperitoneal Chemotherapy Using the FloTrac/Vigileo System.
    Mavroudis C; Alevizos L; Stamou KM; Vogiatzaki T; Eleftheriadis S; Korakianitis O; Tentes AA; Iatrou C
    Int Surg; 2015 Jun; 100(6):1033-9. PubMed ID: 25590363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and cardiovascular problems during modified hyperthermic intraperitoneal perioperative chemotherapy.
    Rankovic VI; Masirevic VP; Pavlov MJ; Ceranic MS; Milenkovic MG; Simic AP; Kecmanovic DM
    Hepatogastroenterology; 2007 Mar; 54(74):364-6. PubMed ID: 17523275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic and hemodynamic changes in patients undergoing open abdominal cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Kim MH; Yoo YC; Bai SJ; Lee KY; Kim N; Lee KY
    J Int Med Res; 2021 Jan; 49(1):300060520983263. PubMed ID: 33445991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anesthetic management in patients undergoing hyperthermic chemotherapy.
    Raspe C; Piso P; Wiesenack C; Bucher M
    Curr Opin Anaesthesiol; 2012 Jun; 25(3):348-55. PubMed ID: 22517311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy.
    Coccolini F; Corbella D; Finazzi P; Brambillasca P; Benigni A; Prussiani V; Ceresoli M; Manfredi R; Poiasina E; Bertoli P; Catena F; Bianchetti A; Bontempelli M; Lorini LF; Sonzogni V; Ansaloni L
    Minerva Anestesiol; 2016 Mar; 82(3):310-9. PubMed ID: 26184701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unreliability of pulse contour-derived cardiac output in piglets simulating acute hemorrhagic shock and rapid volume expansion.
    Lee CH; Wang JY; Huang KL; Chiu HW; Fei TC; Chen TS; Chang H
    J Trauma; 2010 Jun; 68(6):1357-61. PubMed ID: 20539180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of adverse hemodynamic effects of pneumoperitoneum by pressure equilibration.
    Bickel A; Arzomanov T; Ivry S; Zveibl F; Eitan A
    Arch Surg; 2004 Dec; 139(12):1320-5. PubMed ID: 15611457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat CO2 recirculation system.
    Sánchez-García S; Padilla-Valverde D; Villarejo-Campos P; Martín-Fernández J; García-Rojo M; Rodríguez-Martínez M
    Surgery; 2014 Apr; 155(4):719-25. PubMed ID: 24502804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma.
    Rettenmaier MA; Mendivil AA; Gray CM; Chapman AP; Stone MK; Tinnerman EJ; Goldstein BH
    Int J Hyperthermia; 2015 Jun; 31(4):396-402. PubMed ID: 25707816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of variable arterial transducer level on the accuracy of pulse contour waveform-derived measurements in critically ill patients.
    He HW; Liu DW; Long Y; Wang XT; Zhao ML; Lai XL
    J Clin Monit Comput; 2016 Oct; 30(5):569-75. PubMed ID: 26298710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Static and dynamic components of esophageal and central venous pressure during intra-abdominal hypertension.
    Valenza F; Chevallard G; Porro GA; Gattinoni L
    Crit Care Med; 2007 Jun; 35(6):1575-81. PubMed ID: 17452925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.
    Gesson-Paute A; Ferron G; Thomas F; de Lara EC; Chatelut E; Querleu D
    Ann Surg Oncol; 2008 Jan; 15(1):339-44. PubMed ID: 17943387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous hemodynamic monitoring during laparoscopic gastric bypass in superobese patients by pressure recording analytical method.
    Balderi T; Forfori F; Marra V; Di Salvo C; Dorigo M; Anselmino M; Romano SM; Giunta F
    Obes Surg; 2008 Aug; 18(8):1007-14. PubMed ID: 18414959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.
    Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D
    Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot study.
    Argenta PA; Sueblinvong T; Geller MA; Jonson AL; Downs LS; Carson LF; Ivy JJ; Judson PL
    Gynecol Oncol; 2013 Apr; 129(1):81-5. PubMed ID: 23352917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for the treatment of peritoneal carcinomatosis in pediatric solid malignancies: a single institution experience.
    Bautista F; Elias D; Pasqualini C; Valteau-Couanet D; Brugières L
    J Pediatr Surg; 2014 Aug; 49(8):1276-9. PubMed ID: 25092089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.